What Is a Healthy BMR
doi: 10.3389/fmicb.2024.1446595 Received 10 June 2024 Accepted 02 August 2024 Published 14 August 2024 Volume 15 - 2024 Edited by Daniela De Biase, Sapienza University of Rome, Italy Reviewed by Wolfgang Buckel, University of Marburg, Germany Malte Sinn, University of Konstanz, Germany Updates Copyright 2024 Piskol, Lukat, Kaufhold, Heger, Blankenfeldt, Jahn and Moser
Quick Answer: Tirzepatide can typically be stopped without acute medical risk due to its 5-day half-life providing a natural taper, though patients with diabetes require alternative glycemic management and all patients should expect weight regain without intensive lifestyle modification
Patients should never discontinue GLP-1 medications without medical guidance, as abrupt cessation may lead to worsening glycemic control or weight regain
A compounding pharmacy can make a customized version of a medication if your doctor determines that the usual formulation will not work best for you
Pills require less packaging, fewer storage demands, and easier pharmacy fulfillment